Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight

New York, USA, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight The regenerative medicine market is...
June 05, 2026 08:00 ET | Source: Eos SENOLYTIX, Inc.

Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation Forum

HOUSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Eos SENOLYTIX, Inc. (“Eos” or the “Company”), a biotechnology company developing first-in-class mitochondrial-targeted gerotherapeutics designed to improve...
May 07, 2026 13:00 ET | Source: DelveInsight Business Research LLP

PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, May 07, 2026 (GLOBE NEWSWIRE) -- PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The PARP...
May 05, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight

New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations |...
December 04, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight Acute...
July 07, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

New York, USA, July 07, 2025 (GLOBE NEWSWIRE) -- Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The...
November 11, 2024 09:05 ET | Source: Longeveron

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

Longeveron has appointed Devin Blass as Chief Technology Officer (CTO) and SVP of CMC, effective Dec 2, adding capabilities ahead of potential BLA filing.
February 20, 2024 09:00 ET | Source: Transparency Market Research

Thalassemia Treatment Market Expected to Reach USD 1.5 billion by 2031, with a Projected CAGR of 7.3%: Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global thalassemia treatment market is slated to be valued at US$ 1.5 billion in 2031,...
January 17, 2024 08:00 ET | Source: Day One Biopharmaceuticals, Inc.

Day One Announces Two New Appointments to Board of Directors

BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and...
July 06, 2023 16:05 ET | Source: Nasdaq, Inc.

Delisting of Securities of Puhui Wealth Investment Management Co., Ltd.; National Energy Services Reunited Corp.; Bed Bath & Beyond Inc.; IMV Inc.; Celyad Oncology SA; Aptinyx Inc.; Athenex, Inc.; Greencity Acquisition Corporation; QualTek Services Inc.; Bellicum Pharmaceuticals, Inc.; Wejo Group Limited; Cyxtera Technologies, Inc.; HTG Molecular Diagnostics, Inc.; Unico American Corporation; PolarityTE, Inc.; Oncorus, Inc.; and OncoSec Medical Incorporated from The Nasdaq Stock Market

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Puhui Wealth Investment Management Co., Ltd. Puhui Wealth Investment...